Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.

Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.

The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.

7 November 2014
Admission to AIM and first day of dealings


http://www.fever-tree.com/

and a fat lot of help the following :-)

Fevertree Drinks Plc : Berenberg raises target price to 4,250p from 3,350p

Just for interest and if you believe in such things, the pivot, resistance & support levels are :

Pivot R1 R2 R3 S1 S2 S3 S4 S5
3450.00 3536.00 3708.00 3966.00 3278.00 3192.00 2934.00 2676.00 2418.00

That's £30.

£29.

at which level there ought to be some kind of support
anyone brave enough?

S3 is 2771.33.

Structual gap around 22. Surely cant get there in a heartbeat?

Gone under the 200 MA, plenty of support at around £26
Today was one of the largest falls on the chart above, must learn to post them

https://seekingalpha.com/article/4210732-fevertree-panic-selling-warranted

an interesting little article, for which thanks, and of which the following is an extract

Fevertree's shares have always looked rather expensive, commanding a P/E ratio ranging between 50 and 100. What might seem an irrational price tag makes much more sense, considering the growth the company has promised and ultimately delivered. From FY13 to FY17, the company has increased operating profit nearly 2,000% while revenue has risen 726%.

Non-Exec Director and Wife buy’s https://www.moneyam.com/action/news/showArticle?id=6162760

almost sums up the market
having been pounded for the last week and dropping a further 130 at the open, it is now +145 (5.5%)

Directors buy yesterday done the job today

Good chance of bouncing back, overdone.

Action but not clear a Buy or sell, anyone?
https://www.moneyam.com/action/news/showArticle?id=6169913

Looks like a buy taking their holding above 3%.

Morgan Stanley add or sell.. help Skinny again please? https://www.moneyam.com/action/news/showArticle?id=6174124